文献

J-GLOBAL ID：202202259222071422   整理番号：22A0837226

ヨーロッパにおける多分野腫瘍ボードによるオリゴ転移食道胃腫瘍の定義と治療【JST・京大機械翻訳】

Definitions and treatment of oligometastatic oesophagogastric cancer according to multidisciplinary tumour boards in Europe

著者 (56件)： Kroese Tiuri E. (Department of Surgery, Utrecht University Medical Center, Utrecht University, Utrecht, the Netherlands) ,  Kroese Tiuri E. (Department of Radiation Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands) ,  van Hillegersberg Richard (Department of Surgery, Utrecht University Medical Center, Utrecht University, Utrecht, the Netherlands) ,  Schoppmann Sebastian (Department of Surgery, Medical University of Vienna, Vienna University, Vienna, Austria) ,  Deseyne Pieter R.A.J. (Department of Radiation Oncology, Ghent University Hospital, Ghent, Belgium) ,  Nafteux Philippe (Department of Surgery, KU Leuven, Leuven University, Leuven, Belgium) ,  Obermannova Radka (Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute and Faculty of Medicine, Masaryk University Brno, Brno, Czech Republic) ,  Nordsmark Marianne (Department of Radiation Oncology, Aarhus University Medical Center, Aarhus University, Aarhus, Denmark) ,  Pfeiffer Per (Department of Medical Oncology, Odense University Medical Center, University of Odense, Odense, Denmark) ,  Hawkins Maria A. (Medical Physics and Biomedical Engineering, University College London, London, United Kingdom) ,  Smyth Elizabeth (Department of Oncology, Cambridge University Hospitals, Cambridge University, Cambridge, United Kingdom) ,  Markar Sheraz (Department of Surgery, Imperial College London, London University, London, United Kingdom) ,  Hanna George B. (Department of Surgery, Imperial College London, London University, London, United Kingdom) ,  Cheong Edward (Department of Upper GI Surgery, Norfolk & Norwich University Hospital NHS Foundation Trust, Norwich, United Kingdom) ,  Chaudry Asif (Department of Surgery, Royal Marsden Hospital, London University, London, United Kingdom) ,  Elme Anneli (Department of Medical Oncology, Tallinn University Hospital, Tallinn University, Tallinn, Estonia) ,  Adenis Antoine (Department of Medical Oncology, Institute Du Cancer de Montpellier Val D’Aurelle, Lille University, Lille, France) ,  Piessen Guillaume (Department of Surgery, University Hospital C. Huriez, Lille University, Lille, France) ,  Gani Cihan (Department of Radiation Oncology, University Hospital Tubingen, University of Tubingen, Tubingen, Germany) ,  Bruns Christiane J. (Department of Surgery, University Hospital Cologne, University of Cologne, Cologne, Germany) ,  Moehler Markus (Department of Medicine, Johannes Gutenberg-University Clinic, University of Mainz, Mainz, Germany) ,  Liakakos Theodore (Department of Surgery, University of Athens Medical School, University of Athens, Athens, Greece) ,  Reynolds John (Department of Surgery, St. James Hospital, Trinity College Dublin, Dublin, Ireland) ,  Morganti Alessio (Department of Radiation Oncology, University Hospital Bologna, Bologna, Italy) ,  Rosati Riccardo (Department of Surgery, San Raffaele Hospital, San Raffaele Vita-salute University, Milan, Italy) ,  Castoro Carlo (Department of Surgery, Humanitas University Medical Center, Humanitas University, Milan, Italy) ,  D’Ugo Domenico (Department of Surgery, Fondazione Policlinico Universitario Agostino Gemelli, Rome, Italy) ,  Roviello Franco (Department of Surgery, Siena University Hospital, University of Siena, Siena, Italy) ,  Bencivenga Maria (Department of Surgery, University Hospital Verona, University of Vero, Verona, Italy) ,  de Manzoni Giovanni (Department of Surgery, University Hospital Verona, University of Vero, Verona, Italy) ,  Jeene Paul (Department of Radiation Oncology, Radiotherapy, Amsterdam University Medical Centers, Amsterdam, the Netherlands) ,  van Sandick Johanna W. (Department of Surgery, Antoni van Leeuwenhoek, Netherlands Cancer Institute, Amsterdam, the Netherlands) ,  Muijs Christel (Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands) ,  Slingerland Marije (Department of Medical Oncology, University Medical Center Leiden, University of Leiden, Leiden, the Netherlands) ,  Nieuwenhuijzen Grard (Department of Surgery, Catharina Medical Center, Eindhoven, the Netherlands) ,  Wijnhoven Bas (Department of Surgery, Erasmus University Medical Center, University of Rotterdam, Rotterdam, the Netherlands) ,  Beerepoot Laurens V. (Department of Medical Oncology, Elisabeth Tweesteden Ziekenhuis Tilburg, the Netherlands) ,  Kolodziejczyk Piotr (Department of Surgery, Jagiellonian University Medical College, Krakow, Poland) ,  Polkowski Wojciech P. (Department of Surgical Oncology, Medical University of Lublin, Lublin, Poland) ,  Alsina Maria (Department of Medical Oncology, Hospital Universitari Vall D’Hebron and Vall D’Hebron Institute of Oncology (VHIO), Barcelona, Spain) ,  Pera Manuel (Department of Surgery, Hospital Universitario Del Mar, Universitat Autonoma de Barcelona, Barcelona, Spain) ,  Kanonnikoff Tania F. (Department of Medical Oncology, Hospital Clinico Universitario de Valencia, University of Valencia, Valancia, Spain) ,  Nilsson Magnus (Division of Surgery, Department of Clinical Science, Intervention and Technology, Karolinska Institutet and Department of Upper Abdominal Diseases, Karolinska University Hospital, Stockholm, Sweden) ,  Guckenberger Matthias (Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland) ,  Monig Stefan (Department of Surgery, Geneva University Hospitals, University of Geneva, Geneva, Switzerland) ,  Wagner Dorethea (Department of Medical Oncology, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland) ,  Wyrwicz Lucjan (Department of Oncology and Radiotherapy, Maria Sklodowska-Curie Institute - Oncology Center, Warsaw, Poland) ,  Berbee Maaike (Department of Radiation Oncology (MAASTRO), GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre+, Maastricht, the Netherlands) ,  Gockel Ines (Department of Visceral, Transplant, Thoracic and Vascular Surgery, University Hospital Leipzig, University of Leipzig, Leipzig, Germany) ,  Lordick Florian (Department of Medical Oncology, University Hospital Leipzig, University of Leipzig, Leipzig, Germany) ,  Griffiths Ewen A. (Department of Upper Gastrointestinal Surgery, Queen Elizabeth Hospital Birmingham, University Hospital Birmingham NHS Trust, Birmingham, United Kingdom) ,  Griffiths Ewen A. (Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK) ,  Verheij Marcel (Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands) ,  Verheij Marcel (Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands) ,  van Rossum Peter S.N. (Department of Radiation Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands) ,  van Laarhoven Hanneke W.M. (Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands)
資料名： European Journal of Cancer  (European Journal of Cancer)
巻： 164  ページ： 18-29  発行年： 2022年 
JST資料番号： A0802C  ISSN： 0959-8049  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： オランダ (NLD)  言語： 英語 (EN)

抄録/ポイント： オリゴ転移性食道胃がんの定義と治療に関するコンセンサスは不足している。目的:ヨーロッパにおける多分野腫瘍ボード(MDTs)にわたるオリゴ転移食道胃がんの定義と治療を評価すること。ヨーロッパの専門家センター(n=49)は,少なくとも医療,外科,および放射線腫瘍医が存在するMDTにおける15の実生活症例を考察するために要求された。症例は,転移,組織学,検出のタイミング(すなわち,同期対異時性),原発腫瘍治療状態,および全身療法に対する反応に関して,位置および数に関して変化した。一次転帰は,診断時および全身療法後のオリゴ転移疾患の定義における一致であった。二次転帰は治療戦略の一致であった。オリゴ転移疾患に対する治療戦略は,局所治療または全身療法のみを考慮するため,前前頭局所治療(すなわち,転移切除または定位放射線療法),全身療法,続く休息にカテゴリー化した。MDTsの一致は,欠如/不良(<50%),公正(50%~75%),またはコンセンサス(≧75%)であった。16か国にわたる合計47のMDTsは,症例(96%)を完全に議論した。肝臓,肺,後腹膜リンパ節,副腎,軟部組織または骨(コンセンサス)のいずれかで1~2の転移を有する患者において,オリゴ転移疾患を考慮した。追跡調査では,オリゴ転移病変(s)のみの進行性または進行が見られなかった場合,全身療法の中央値18週後に,オリゴ転移疾患が考えられた(コンセンサス)。全身療法の18週の中央値後の休息時に,病変の数は進行し,これはオリゴ転移疾患とは考えられなかった(フェア一致)。オリゴ転移疾患に対する治療戦略に関するコンセンサスはなかった。オリゴ転移性食道胃がんの定義に関する広範なコンセンサスが,ヨーロッパにおける食道胃がん専門センターのMDTsの間で見出された。しかし,治療戦略における高い実践変動性が存在する。Copyright 2022 Elsevier B.V., Amsterdam. All rights reserved. Translated from English into Japanese by JST.【JST・京大機械翻訳】

シソーラス用語： *腫瘍 ,  副腎 ,  リンパ節 ,  *食道 ,  腫瘍転移 ,  *治療法 ,  休憩 ,  軟部組織 ,  *胃腫瘍 ,  治療計画 ,  後腹膜腔
準シソーラス用語： 局所治療 ,  定位放射線手術 ,  全身療法 ,  転移性 , 【Automatic Indexing@JST】

著者キーワード (6件)： 食道腫瘍 ,  胃腫瘍 ,  腫瘍転移 ,  転移切除 ,  放射線外科 ,  オリゴメタスタシス

分類 (2件)： 消化器の腫よう  (GH04000D) ,  腫ようの治療一般  (GE03031L)

タイトルに関連する用語 (7件)： ヨーロッパ ,  腫瘍 ,  ボード ,  食道 ,  胃腫瘍 ,  定義 ,  治療